双侧切口白内障囊外摘除联合人工晶状体植入术疗效观察  

Clinical outcomes of bilateral incision in extracapsular cataract extirpation and IOL implantation

作　　者：文中华[1] 廖妙云[1] 丁芝祥[1] 曾新生[1] 张玉明[1] 

机构地区：[1]桂林医学院附属医院眼科,541001

出　　处：《临床眼科杂志》2015年第5期423-425,共3页Journal of Clinical Ophthalmology

摘　　要：目的观察分别采用双侧切口与单侧切口白内障囊外摘除联合人工晶状体植入术临床效果及术后并发症比较。方法采用回顾性病例对照研究。收集我院白内障患者100例(130只眼),采用随机数字表法将其分为观察组(65只眼)和对照组(65只眼),对应随机数字为偶数者为观察组,奇数者为对照组。观察组采取双侧切口白内障囊外摘除联合人工晶状体植入术治疗,对照组采取单侧切口白内障囊外摘除联合人工晶状体植入术治疗,观察手术后视力及术中出现后囊膜破裂、虹膜脱出等并发症的情况,术后出现角膜内皮水肿、晶状体皮质残留发生率等并发症的情况。结果采用双侧切口与单侧切口白内障囊外摘除联合人工晶状体植入术术后视力无显著差异,差异无统计学意义(P>0.05);但观察组术中出现后囊膜破裂、虹膜脱出等并发症明显少于对照组,差异具有统计学意义(P<0.05);观察组术后出现的角膜内皮水肿、晶状体皮质残留发生等并发症较对照组低,差异具有统计学意义(P<0.05)。结论采用双侧切口白内障囊外摘除联合人工晶状体植入术可以减少术中术后并发症的发生,具有安全性和经济性等特点,值得在临床上进一步推广应用。Objective To compare the postoperative complications in patients received unilateral incision versus bilateral incision for extracapusular cataract extirpation（ ECCE） and IOL implantation. Methods This is a retrospective case control study. Author collected clinical data of 200 cataract patients（ 232 eyes）. Patients were randomly divided into observation group（ 65 eyes） and control group（ 65 eyes）. The observation group received bilateral incision ECCE and IOL implantation,while the control group received unilateral incision ECCE and IOL implantation. Posterior capsular rupture,iris prolapse,endothelium edema,residual capsule,and postoperative visual acuity were compared. Results There was no difference in visual acuity outcomes between the two groups（ P〉0. 05）. However,the patients in the observation group tended to have significantly less intraoperative complications such as posterior capsule rupture or iris prolapse（ P〈0. 05）. Postoperatively,corneal endothelial edema and residual lens cortex were also significantly less frequent in observation group than in control group（ P〈0. 05） Conclusion Bilateral incision for ECCE and IOL implantation can reduce surgical complications and is therefore safer and worth wider clinical applications.

关 键 词：双侧切口 单侧切口 白内障 囊外摘除术 人工晶状体植入术 

分 类 号：R779.66[医药卫生—眼科]